Idiopathic pulmonary fibrosis (IPF) is one of the most frequent fibrotic diseases of the interstitium and, according to the article, possibly the most serious. When untreated, this disease is associated with a median survival between 3 and 5 years after diagnosis.
On World Disease Day, commemorated on September 7th, the Portuguese Society of Pulmonology (SPP) issued an alert about the challenges that continue to affect patients with this condition.
According to the article, lack of awareness about the disease and late diagnosis remain significant obstacles in the treatment of idiopathic pulmonary fibrosis, hindering early intervention and patient prognosis.
